We greatly appreciate the support of the patients and their families for participation in this study and cardiologists who participated in this study. This work was supported by grants from the National Natural Science Foundation of China (No. 30470722, 30771982 and 30772356) and the Beijing Natural Science Foundation (No. 7032012, 7052021 and No. 7062010). The authors have no conflicts of interest to declare.
Background Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metabolism which can lead to premature coronary heart disease (pCHD). There are about 3.8 million potential FH patient...
This study was supported by grants from the National Natural Science Foundation of China (No. 30470722, 30771986, 30772356), Beijing Natural Science Foundation (No. 7092016, 7062010, 7052021), and Key Project for Applicable Basic Research of Hunan Province (No. 2008FJ2006).
Background Familial hypercholesterolemia (FH) is an autosomal disorder associated with elevated plasma low density lipoprotein (LDL) levels leading to premature coronary heart disease (CHD). As a result of long-...
This study was supported by grants from the National Natural Science Foundation of China (No, 30470722, 30771982, 30772356), Beijing Natural Science Foundation (No. 7052021, 7062010), and Science and Technology New Star Funds of Beijing (No. 2004B27, 2005A29)
Background Familial hypercholesterolemia (FH), caused by low density lipoprotein (LDL) receptor (LDL-R) gene mutations, is associated with increased risk of premature coronary heart disease. Until now, limited m...